| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/23/1999 | CA2323418A1 Nonnucleoside inhibitors of reverse transcriptase for the treatment of hiv-infection |
| 09/23/1999 | CA2322994A1 Topical antiseptic compositions and methods |
| 09/23/1999 | CA2322742A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 09/23/1999 | CA2321091A1 An equine neospora isolate and its uses |
| 09/23/1999 | CA2320167A1 1,3,4-thiadiazoles useful for the treatment of cmv infections |
| 09/23/1999 | CA2288881A1 Therapeutic agent for preventing and/or treating sepsis |
| 09/23/1999 | CA2288679A1 Process for the production of virus in cell cultures |
| 09/22/1999 | EP0943623A1 Cyclic hexapeptide antifungal agents |
| 09/22/1999 | EP0943616A1 Substituted imidazole derivatives and their use as cytokine inhibitors |
| 09/22/1999 | EP0943005A1 Tissue specific and target rna-specific ribozymes as antimicrobial therapeutics against microbial pathogens |
| 09/22/1999 | EP0942998A1 Notch |
| 09/22/1999 | EP0942988A1 Hiv envelope polypeptides and vaccine |
| 09/22/1999 | EP0942987A1 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 09/22/1999 | EP0942984A2 C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE) |
| 09/22/1999 | EP0942983A2 $i(STREPTOCOCCUS PNEUMONIAE) ANTIGENS AND VACCINES |
| 09/22/1999 | EP0942982A1 Bacterial elastin binding protein, nucleic acid sequence encoding same and diagnostic and therapeutic methods of use thereof |
| 09/22/1999 | EP0942974A2 Secreted proteins and polynucleotides encoding them |
| 09/22/1999 | EP0942964A2 Thermostable polymerases having altered fidelity |
| 09/22/1999 | EP0942928A1 Subunit respiratory syncytial virus vaccine preparation |
| 09/22/1999 | EP0942916A2 Nucleosides |
| 09/22/1999 | EP0942907A1 2r, 4s, s, r- and 2s, 4r, s, r-hydroxyitraconazole |
| 09/22/1999 | EP0942902A2 Novel immunotherapeutic imides/amides |
| 09/22/1999 | EP0942901A1 Cyclic imines as pesticides |
| 09/22/1999 | EP0942748A1 Env-glycoprotein vaccine for protection of htlv-i and -ii infection |
| 09/22/1999 | EP0942721A1 Pharmaceutical composition |
| 09/22/1999 | EP0772615B1 IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 09/22/1999 | EP0540525B1 Method of preparation of vaccines, and the use of the vaccines thus prepared |
| 09/22/1999 | EP0517836B1 Method and product for promoting hair growth and treating skin conditions |
| 09/22/1999 | CN1229438A Erythromycins and process for their preparation |
| 09/22/1999 | CN1229434A Method of attenuating viruses |
| 09/22/1999 | CN1229414A Multivalent compounds for cross-linking receptors and uses thereof |
| 09/22/1999 | CN1229412A Inhibitors of interleukin-1'beta' converting emzyme |
| 09/22/1999 | CN1229411A Crystal form I of clarithromycin |
| 09/22/1999 | CN1229359A Dendritic cell stimulatory factor |
| 09/22/1999 | CN1229358A Method for generating bi-RNA-virus from synthetic RNA transcripts |
| 09/22/1999 | CN1229357A Method of inhibiting fibrosis with growth inhibition excitant |
| 09/22/1999 | CN1229085A Beta,beta-disubstituted derivatives of 9-deoxo-9a-N-ethenyl-9a-homoerythromycin A |
| 09/22/1999 | CN1229084A Unsaturated phosphate derivatives of purines and pyrimidines |
| 09/22/1999 | CN1229082A Amine compound and its acid addition salt |
| 09/22/1999 | CN1229080A Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides |
| 09/22/1999 | CN1229079A Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides |
| 09/22/1999 | CN1229078A Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides |
| 09/22/1999 | CN1229077A Process for preparation of 3-amino-pyrrolidine derivatives |
| 09/21/1999 | US5955593 BH3 interacting domain death agonist |
| 09/21/1999 | US5955589 Gapped 2' modified oligonucleotides |
| 09/21/1999 | US5955580 Vaccines for nontypable haemophilus influenzae |
| 09/21/1999 | US5955571 Novel n-branched nucleic acids with non-ribose phosphate backbone; for use in controlling gene expression, antisense agents, viricides, diagnosis, and genetic engineering techniques |
| 09/21/1999 | US5955476 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels |
| 09/21/1999 | US5955460 Oxazolidinone antibacterial agent with tricyclic substituents |
| 09/21/1999 | US5955458 Penicillin glycolate |
| 09/21/1999 | US5955457 Water soluble rapamycin esters |
| 09/21/1999 | US5955452 Covalent lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments |
| 09/21/1999 | US5955449 Diagnosis and treatment of bacterial dysentery |
| 09/21/1999 | US5955446 Viricides for herpes infections |
| 09/21/1999 | US5955427 Pharmaceutical composition |
| 09/21/1999 | US5955364 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
| 09/21/1999 | US5955356 Nucleic acids, vectors, and host cells including mycobacterium derived sequences |
| 09/21/1999 | US5955337 Lyase enzyme which can be used to screen fungicidal compounds |
| 09/21/1999 | US5955309 Polynucleotide encoding G-protein coupled receptor (H7TBA62) |
| 09/21/1999 | US5955308 cDNA clone HEAOD54 that encodes a human 7-transmembrane receptor |
| 09/21/1999 | US5955303 Human chemokine receptor-like protein |
| 09/21/1999 | US5955260 Antibodies that bind viral proteins that share homogeneity; for diagnostic immunoassay of virus in sample |
| 09/21/1999 | US5955090 Immunogenic hybrid protein OprF-OprI derived from Pseudomonas aeruginosa membrane proteins |
| 09/21/1999 | US5955089 Streptococcus for vaccines |
| 09/21/1999 | US5955088 Pharmaceutical compsition of herpes simplex virus type-1 (HSV-1), glycoproteins |
| 09/21/1999 | US5955087 Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation |
| 09/21/1999 | US5955078 Novel polypeptides and monoclonal antibodies, preparation and use to combat infection at the site of wounds, surgical implants and other in-dwelling devices such as catheters |
| 09/21/1999 | US5955077 Tuberculosis vaccine |
| 09/21/1999 | US5955074 Directed human immune globulin for the prevention and treatment of staphylococcal infections |
| 09/21/1999 | CA2179286C Broad spectrum antimicrobial compounds and methods of use |
| 09/21/1999 | CA2152269C Process for preparing substituted 1,3-oxathiolanes with antiviral properties |
| 09/21/1999 | CA2145313C Antimicrobial peptides |
| 09/21/1999 | CA2012867C Novel cytotoxic cyclic depsipeptides from the tunicate trididemnum solidum |
| 09/16/1999 | WO1999046390A1 Chitinase chitin-binding fragments |
| 09/16/1999 | WO1999046372A2 Ribozymes capable of inhibiting the expression of the ccr5 receptor |
| 09/16/1999 | WO1999046283A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 09/16/1999 | WO1999046275A1 REPLICATIVE HELICASE dnaB OF $i(STAPHYLOCOCCUS AUREUS) |
| 09/16/1999 | WO1999046268A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 09/16/1999 | WO1999046248A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 09/16/1999 | WO1999046242A1 Cycloalkene derivatives, process for producing the same, and use |
| 09/16/1999 | WO1999046237A1 Modulators of protein tyrosine phosphatases |
| 09/16/1999 | WO1999045963A1 Analgesic combination comprising nmda receptor antagonists and narcotic analgesics |
| 09/16/1999 | WO1999045959A1 Humanized antibody and uses thereof |
| 09/16/1999 | WO1999045957A2 Combined vaccine compositions |
| 09/16/1999 | WO1999045956A1 Vaccines against circovirus infections |
| 09/16/1999 | WO1999045954A1 Hla-binding peptides and their uses |
| 09/16/1999 | WO1999045935A1 Novel nucleoside analogs and uses in treating disease |
| 09/16/1999 | WO1999045908A2 Anti-viral uses of leflunomide products |
| 09/16/1999 | WO1999045904A1 Delivery system to modulate immune response |
| 09/16/1999 | WO1999045788A1 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 09/16/1999 | WO1999036091A3 Method for inhibiting cd95-independent apoptosis in aids |
| 09/16/1999 | WO1999033868A3 Human papillomavirus vaccine |
| 09/16/1999 | WO1999029321A9 Inhibition of membrane-associated viral replication |
| 09/16/1999 | WO1996012802A9 Vaccine and antitoxin for treatment and prevention of c. difficile disease |
| 09/16/1999 | CA2323787A1 Humanized antibody and uses thereof |
| 09/16/1999 | CA2323632A1 Hla-binding peptides and their uses |
| 09/16/1999 | CA2323493A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 09/16/1999 | CA2323109A1 Ribozymes capable of inhibiting the expression of the ccr5 receptor |
| 09/16/1999 | CA2323070A1 Chitinase chitin-binding fragments |
| 09/16/1999 | CA2322494A1 Novel nucleoside analogs and uses in treating disease |